ACTIVE SESSION TAPE Biotechnology $26M Cap Quant: STRONG SELL

Why Is Passage Bio, Inc. (PASG) Stock Down Today?

Updated Nov 16, 2026 5:42 PM ET · Prev Close $4.25

Pro Workspace
Last Session Price
$4.13 -2.82%
-$0.12 vs $4.25 prior close
Intraday Range
$3.84 – $4.20
Open $4.12
Relative Volume
1.12x Avg
16,998 sh
52-Week Range
$3.29 – $20.00
Benchmark Alpha
-0.91% vs SPY
-0.15% vs QQQ
20-Session Trend +14.7%

Session Regime & Catalyst Assessment

68% Signal Conviction
SECTOR 68% Driver Weight

Passage Bio, Inc. Pulling Back 2.82% on 1.12x Relative Volume

Passage Bio, Inc. (PASG) is pulling back 2.82% (-$0.12) to $4.13 on 1.12x average session volume. Relative to benchmarks, PASG is lagging the S&P 500 by -0.91%. 14-day RSI stands at 57.0, keeping momentum in a bullish regime.

NEWS 70% Weight
Remix to go public in reverse merger with once high-flying Passage Bio

The transaction marks the latest turn in the fortunes of Passage Bio, one of the companies started by gene therapy pioneer Jim Wilson.

TECHNICAL 68% Weight
Moving Average Structure: Mixed Alignment

Price ($4.13) holds above both 20-day ($3.62) and 50-day ($4.10) moving averages.

Volume Confirmation
MODERATE VOLUME (1.12x) Normal
Institutional participation confirms directional price action.
Composite Catalyst Confidence 68%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

PASG lagging the S&P 500 by -0.91%
PASG Session
-2.82%
$4.13
S&P 500 (SPY)
-1.91%
$739.95
Nasdaq 100 (QQQ)
-2.67%
$661.75
Healthcare (XLV)
-0.51%
$187.88
Alpha vs SPY: -0.91% Alpha vs QQQ: -0.15% Alpha vs XLV: -2.31%

Recent PASG Catalyst Headlines

Verified Wire
Passage Bio and Remix Therapeutics Announce Merger Agreement

Combined company to operate as Remix Therapeutics and advance Remix s pipeline of novel small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin Remix s lead program, REM-

Yahoo Finance · Jun 24, 2026

1–3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$3.90
Short-term support band
Upper Bound
$4.36
Short-term resistance band
Key Inflection Level
$4.10 (50-day SMA support)

Monitor volume expansion above 1.5x RVOL around $4.10 (50-day SMA support) for directional breakout confirmation.

Technical Regime (PASG)

MIXED MA TREND
RSI (14)
57.0
Bullish
20-Day SMA
$3.62
Above 20d
50-Day SMA
$4.10
Above 50d
MACD Signal
Bullish
MACD 0.03
ADX (14)
29.0
Strong trend
10d Momentum
+0.81
Positive 10-day momentum

Retail & Crowd Sentiment

Neutral
24h Messages
0
7d avg 0.0
Bullish / Bearish
0.0% / 0.0%
None buzz
Crowd Discussion Digest

Passage Bio signed an all-stock merger deal with Remix Therapeutics, but the stock price dropped significantly after hours despite the bullish news.

Reddit communities: 1 comment (Neutral)

About Passage Bio, Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative …

Sector
Healthcare
Market Cap
$26M
Employees
60

Get Instant PASG Catalyst Alerts

Receive an email alert when PASG triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

PASG Session & Catalyst FAQ

Why is PASG stock down today?

Passage Bio, Inc. (PASG) is pulling back 2.82% (-$0.12) to $4.13 on 1.12x average session volume. Relative to benchmarks, PASG is lagging the S&P 500 by -0.91%. 14-day RSI stands at 57.0, keeping momentum in a bullish regime.

Is PASG stock a buy or sell right now?

Today's session carries a 68% catalyst conviction score on 1.12x relative volume (moderate participation). Our multi-factor model currently rates PASG as STRONG SELL. Review full valuation, quality, and timing signals on the PASG Buy or Sell Decision Brief →

What is PASG's intrinsic value and expected trading range?

At $4.13, PASG's modeled 1-to-3 session range is $3.90 – $4.36, with a key inflection level at $4.10 (50-day SMA support). Compare current price against multi-year cash flow projections in the PASG Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for PASG?

RSI at 57.0 reflects constructive bullish momentum. PASG trades at $4.13 relative to its 20-day SMA ($3.62) and 50-day SMA ($4.10), reflecting a mixed moving-average structure.

Tradestie Flagship Research & Market Hubs